Exact Sciences Corporation (FRA:EXK)
86.44
+0.11 (0.13%)
At close: Dec 4, 2025
Exact Sciences Revenue
Exact Sciences had revenue of $850.74M USD in the quarter ending September 30, 2025, with 20.05% growth. This brings the company's revenue in the last twelve months to $3.08B, up 14.47% year-over-year. In the year 2024, Exact Sciences had annual revenue of $2.76B with 10.37% growth.
Revenue (ttm)
$3.08B
Revenue Growth
+14.47%
P/S Ratio
6.26
Revenue / Employee
$440.29K
Employees
7,000
Market Cap
16.46B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.76B | 259.10M | 10.37% |
| Dec 31, 2023 | 2.50B | 415.49M | 19.93% |
| Dec 31, 2022 | 2.08B | 317.19M | 17.95% |
| Dec 31, 2021 | 1.77B | 275.70M | 18.49% |
| Dec 31, 2020 | 1.49B | 615.10M | 70.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Exact Sciences News
- 2 days ago - Noteworthy ETF Inflows: XBI, EXAS, RVMD, RNA - Nasdaq
- 3 days ago - Top 2 Health Care Stocks You May Want To Dump This Month - Benzinga
- 4 days ago - $100 Invested In Exact Sciences 15 Years Ago Would Be Worth This Much Today - Benzinga
- 10 days ago - Here's How Much You Would Have Made Owning Exact Sciences Stock In The Last 15 Years - Benzinga
- 10 days ago - EXAS Quantitative Stock Analysis - Nasdaq
- 10 days ago - This Coinbase Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
- 10 days ago - Exact Sciences (EXAS) Downgraded by Canaccord Genuity, PT Raised to $105 | EXAS Stock News - GuruFocus
- 10 days ago - Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More - 24/7 Wall street